A patent examiner’s decision to grant a patent is not the final word on its validity. Patent offices operate under time and resource constraints; prior art is sometimes missed; and claim language that passes initial examination may later be found to exceed the bounds of what the inventor actually invented. Every major patent system therefore provides a mechanism for third parties to challenge the validity of granted patents. In Japan, this mechanism is the patent invalidation trial (特許無効審判). This article explains how it works, what it accomplishes, and how it compares to equivalent procedures in the US and Europe.
Grounds for Invalidity Under Japan’s Patent Act
Article 123(1) of the Patent Act specifies the grounds on which a patent may be declared invalid. The most practically significant are:
- Failure to meet patentability requirements (lack of novelty, lack of inventive step, lack of industrial applicability, or unpatentable subject matter) — Article 123(1)(ii)
- Failure to meet disclosure requirements (insufficient description, unsupported claims, or indefinite claims) — Article 123(1)(iv)
- Filing by a person not entitled to the patent (fraudulent applicant or absence of assignment from the actual inventor) — Article 123(1)(vi)
- Violation of treaty obligations — Article 123(1)(iii)
In practice, the vast majority of invalidation trials are brought on the grounds of novelty or inventive step deficiency (Article 123(1)(ii)), often combined with a disclosure deficiency argument. According to IP High Court statistics, novelty and inventive step grounds account for more than half of all invalidation trial requests in recent years.
Who Can File: The “Any Person” Standard
Under Article 123(2), “any person” may request a patent invalidation trial. This broad standing—which includes competitors, defendants in infringement suits, researchers, industry associations, and the general public—reflects the public interest in clearing invalid patents from the landscape. Japan does not limit standing to parties who can demonstrate a particular economic stake in the outcome.
This contrasts with the US inter partes review system (discussed below), which requires a petitioner to certify that it is not estopped from challenging the patent’s claims based on a prior court or USPTO proceeding. Japan’s absence of such restrictions makes its invalidation trials particularly accessible.
Procedure: From Filing to Decision
A request for an invalidation trial is filed with the JPO’s Trial and Appeal Department (審判部). The request must specify the claims at issue, the legal grounds, the evidence (typically prior art references), and the reasoning supporting invalidity.
The patent owner is served with the request and may submit a written response (答弁書) and, crucially, a request for correction (訂正請求) of the patent claims under Article 134-2. A correction request allows the patent owner to narrow or clarify claims to distinguish them from the cited prior art—a defensive tactic that can defeat the invalidity argument if successful. The interaction between the correction request and the invalidity grounds often determines the trial’s outcome.
An oral hearing may be convened where the parties present arguments and evidence directly (Trial Regulations, Article 45). The trial panel consists of three or five trial examiners (審判官). The average pendency from request to decision is approximately 12–14 months (FY2023 JPO statistics).
If the panel finds the patent invalid (無効審決), the patent is deemed never to have existed from the beginning (Patent Act, Article 125). This retroactive effect means that all past enforcement—including injunctions and damages awards—rests on a foundation that has been removed. A party that paid damages under a now-invalid patent may have claims for restitution, though the interplay with res judicata in prior civil litigation is complex.
An adverse decision (either an invalidity decision or a decision maintaining the patent) may be challenged before the IP High Court within 30 days of receiving the written decision (Article 178). The IP High Court hears patent appeals before technically specialized panels and may examine both legal and technical questions.
Coordinating Invalidation Trials with Infringement Litigation
In Japan, a defendant in a patent infringement suit may simultaneously pursue two avenues: raising a patent invalidity defense directly in the infringement court (Article 104-3, confirmed by the Supreme Court’s Kilby decision, April 11, 2000) and filing a separate invalidation trial before the JPO.
This dual-track approach is standard practice in contested patent litigation. The infringement court applies the invalidity defense under Article 104-3 using a “clear invalidity” standard (明らかに無効): if the court finds the patent clearly invalid, it may deny the patentee’s claims even without waiting for a formal JPO invalidation decision. A full JPO invalidity trial may run in parallel, potentially producing a definitive finding.
When a JPO invalidation decision becomes final, courts must give it legal effect—a final invalidity decision removes the patent and retroactively undermines any infringement finding. Courts sometimes stay infringement proceedings pending the outcome of a related invalidation trial, though this is not mandatory and each court exercises its discretion.
Correction Trials: A Proactive Patent Maintenance Tool
A patent owner who perceives a vulnerability in existing claims may proactively file a correction trial (訂正審判, Article 126) before any invalidation proceeding is initiated. A correction trial allows narrowing or clarifying claims to forestall future invalidity arguments. However, while a correction trial is pending, invalidation trials cannot be filed against the same patent (Article 127), creating a temporary shield. Once an invalidation trial is filed, the correction procedure shifts to a correction request within that trial.
US Inter Partes Review (IPR)
The America Invents Act (AIA, 2011) replaced the earlier inter partes reexamination with IPR, administered by the Patent Trial and Appeal Board (PTAB). IPR is available only within one year of the petitioner being served with a complaint alleging infringement of the patent. IPR grounds are limited to anticipation (lack of novelty) and obviousness (lack of inventive step) based on patents or printed publications—the same grounds as Japan’s invalidation trial but excluding §101 subject matter eligibility and §112 written description challenges, which must be raised elsewhere.
Key features of IPR: the preponderance of evidence standard (lower than the clear and convincing evidence standard applied in district court invalidity challenges); a target completion date of 12 months from institution; and an institution decision in which the PTAB evaluates whether there is a “reasonable likelihood” that the petitioner would prevail on at least one challenged claim. Post-AIA statistics show that approximately 60–70% of claims that reach final written decision in an IPR are found unpatentable—earning the PTAB the reputation as a “patent death squad” in certain industry circles, though this characterization overstates the actual cancellation rate across all petitioned claims.
EPO Opposition Proceedings
European patents granted by the EPO can be opposed by any third party within nine months of the grant publication date (EPC Article 99). Opposition must be based on specified grounds including lack of novelty, lack of inventive step, or insufficient disclosure (Rule 76 EPC). The proceedings are conducted before the EPO’s Opposition Division; appeals go to the EPO’s Boards of Appeal.
A distinctive feature of EPO oppositions is the ability of the patent owner to submit “auxiliary requests”—progressively narrower versions of the claims—during the opposition proceedings. If the main claim is found invalid, the patent may survive in amended form under an auxiliary request. The outcome of an EPO opposition affects the patent across all validation countries simultaneously—making a single successful opposition more economically efficient than attacking the same patent separately in each national court.
| Feature | Japan Invalidation Trial | US IPR | EPO Opposition |
|---|---|---|---|
| Filing deadline | No time limit | Within 1 year of infringement suit service | Within 9 months of grant publication |
| Standing | Any person | Third parties (with estoppel rules) | Any person |
| Invalidity grounds | Novelty, inventive step, disclosure, etc. | Novelty, inventive step (patents/publications only) | Novelty, inventive step, disclosure, etc. |
| Average pendency | ~12–14 months | ~12–18 months | ~2–4 years |
| Invalidity rate | ~30–40% of requests | ~60–70% of instituted claims | ~30–50% |
The final article in this series addresses software patents and business method patents—the most contested territory of modern patent law, where the same invention may be patentable in one jurisdiction and categorically rejected in another.
コメント